Advertisement

2021 to 2023 Saw Considerable Increase in Semaglutide Fills

0

Ozempic accounted for more than 70 percent of these fills, but increases were seen for all three drug brands

Brand of Kratom Tied to One Death, Many Severe Illnesses, FDA Warns

0
By Ernie Mundell HealthDay Reporter MONDAY, Aug 5, 2024 (HealthDay News) -- Millions of Americans use the opioid-like herbal supplement known as kratom, but evidence...

FDA Approves Leqselvi for Severe Alopecia

0

JAK inhibitor associated with significant improvements in scalp hair coverage at 24 weeks

Semaglutide Products Being Sold Online Without Prescriptions

0

Semaglutide was revealed in all samples purchased from online vendors, with considerably low purity levels

Suicide Rates on the Rise for Asian American and Pacific Islander Youths

0

Increases in recent years were preceded by declining trends for both male and female youths

State-Level COVID-19 Restrictions Helped Save Lives

0

However, not all measures were equally effective, according to recent study

Mpox Has Surged in Africa Amid Shortages of Vaccines and Treatments

0
By Robin Foster HealthDay Reporter FRIDAY, Aug. 2, 2024 (HealthDay News) -- Mpox cases have soared by 160% in Africa this year, as a lack...

Availability Increased With Approval of Naloxone as OTC Medication

0

Mean quoted out-of-pocket cost decreased pre- to post-OTC availability, with higher mean costs at independent pharmacies

Long-Term Low-Carb Diet Efficacious for Treating Dyslipidemia in T2D

0

However, no significant differences seen in changes in glycated hemoglobin between long-term low-carb and control diets

CDC Report Addresses Nonfinancial Access Barriers to Care in 2022

0

12.5 percent of U.S. adults delayed or did not get medical care in past 12 months because they were too busy to go to a provider